Edition:
United States

Trans Genic Inc (2342.T)

2342.T on Tokyo Stock Exchange

636JPY
22 Sep 2017
Change (% chg)

¥-5 (-0.78%)
Prev Close
¥641
Open
¥647
Day's High
¥647
Day's Low
¥626
Volume
273,100
Avg. Vol
688,482
52-wk High
¥918
52-wk Low
¥540

Chart for

About

TRANS GENIC INC. is a company engaged in the biotechnology business. The Company operates in four business segments. The Genomics segment is engaged in the licensing of genetic information, the manufacturing contract of genetic knockout mice, and the gene analysis contract business, among others. The Contract Research Organizati... (more)
No analyst recommendations are available for .

Overall

Beta: 0.55
Market Cap(Mil.): ¥9,301.46
Shares Outstanding(Mil.): 14.62
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 81.40 16.08
EPS (TTM): -- -- --
ROI: -- 3.18 14.60
ROE: -- 4.93 14.03

BRIEF-Trans Genic unit concludes license agreement with AIST related to mouse model for mental disorder

* Says unit New Drug Research Center Inc.,Ltd. concluded a license agreement with National Institute of Advanced Industrial Science and Technology on July 10, regarding mouse model for mental disorder

Jul 10 2017

BRIEF- Trans Genic announces joint research agreement with Immuno-Biological Laboratories

* Says it signs a joint research agreement with Immuno-Biological Laboratories Co Ltd, regarding Alzheimer's disease therapeutic drugs

Jun 26 2017

BRIEF-Trans Genic concludes license agreement with Osaka City University and professor

* Says it concluded a license agreement with Osaka City University and a professor of Osaka City University on June 20

Jun 20 2017

Earnings vs. Estimates